KalVista Pharmaceuticals(KALV) - 2026 Q1 - Earnings Call Transcript

KalVista Pharmaceuticals (NasdaqGM:KALV) Q1 2026 Earnings Call September 11, 2025 08:30 AM ET Company ParticipantsRyan Baker - Head - IRBenjamin Palleiko - Director & CEONicole Sweeny - CCOBrian Piekos - CFOPaul Matteis - MD & Head - Therapeutics ResearchTazeen Ahmad - MD - US Equity ResearchPete Stavropoulos - Director - Biotech Equity ResearchDebanjana Chatterjee - Vice PresidentConference Call ParticipantsStacy Ku - Biotechnology Equity Research AnalystMaury Raycroft - Equity Research AnalystWill Soghiki ...